Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.
Lonchay
Christophe
C
Ludwig Institute for Cancer Research, Brussels Branch of Human Cell Genetics, Université de Louvain, 74 Avenue Hippocrate, UCL 7459, B-1200 Brussels, Belgium.
van der Bruggen
Pierre
P
Connerotte
Thierry
T
Hanagiri
Takeshi
T
Coulie
Pierre
P
Colau
Didier
D
Lucas
Sophie
S
Van Pel
Aline
A
Thielemans
Kris
K
van Baren
Nicolas
N
Boon
Thierry
T
D000595:Amino Acid Sequence; D000951:Antigens, Neoplasm / Q000235:genetics; D028121:Canarypox virus / Q000235:genetics; D019496:Cancer Vaccines / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D022801:Complementarity Determining Regions; D003602:Cytotoxicity, Immunologic; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D066298:In Vitro Techniques; D008545:Melanoma / Q000276:immunology* / Q000556:secondary / Q000628:therapy*; D009363:Neoplasm Proteins / Q000235:genetics; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D022801:Complementarity Determining Regions; C072013:MAGEA3 protein, human; D009363:Neoplasm Proteins